BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26418877)

  • 1. The Vacuolar ATPase a2-subunit regulates Notch signaling in triple-negative breast cancer cells.
    Pamarthy S; Jaiswal MK; Kulshreshtha A; Katara GK; Gilman-Sachs A; Beaman KD
    Oncotarget; 2015 Oct; 6(33):34206-20. PubMed ID: 26418877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The V-ATPase a2 isoform controls mammary gland development through Notch and TGF-β signaling.
    Pamarthy S; Mao L; Katara GK; Fleetwood S; Kulshreshta A; Gilman-Sachs A; Beaman KD
    Cell Death Dis; 2016 Nov; 7(11):e2443. PubMed ID: 27809299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.
    Zhang J; Shao X; Sun H; Liu K; Ding Z; Chen J; Fang L; Su W; Hong Y; Li H; Li H
    Oncotarget; 2016 Sep; 7(38):61036-61053. PubMed ID: 27506933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo anti-V-ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses.
    Kulshrestha A; Katara GK; Ibrahim SA; Riehl VE; Schneiderman S; Bilal M; Young AN; Levine S; Fleetwood S; Dolan J; Gilman-Sachs A; Beaman KD
    Mol Oncol; 2020 Oct; 14(10):2436-2454. PubMed ID: 32797726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer associated a2 isoform vacuolar ATPase immunomodulates neutrophils: potential role in tumor progression.
    Ibrahim SA; Katara GK; Kulshrestha A; Jaiswal MK; Amin MA; Beaman KD
    Oncotarget; 2015 Oct; 6(32):33033-45. PubMed ID: 26460736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of vacuolar ATPase subunit in tumor cells delays tumor growth by decreasing the essential macrophage population in the tumor microenvironment.
    Katara GK; Kulshrestha A; Jaiswal MK; Pamarthy S; Gilman-Sachs A; Beaman KD
    Oncogene; 2016 Feb; 35(8):1058-65. PubMed ID: 25961933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOTCH4 is a potential therapeutic target for triple-negative breast cancer.
    Nagamatsu I; Onishi H; Matsushita S; Kubo M; Kai M; Imaizumi A; Nakano K; Hattori M; Oda Y; Tanaka M; Katano M
    Anticancer Res; 2014 Jan; 34(1):69-80. PubMed ID: 24403446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vacuolar ATPase 'a2' isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancer.
    Kulshrestha A; Katara GK; Ibrahim S; Pamarthy S; Jaiswal MK; Gilman Sachs A; Beaman KD
    Oncotarget; 2015 Feb; 6(6):3797-810. PubMed ID: 25686833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated vacuolar ATPase subunit promotes tumorigenic characteristics in macrophages.
    Katara GK; Jaiswal MK; Kulshrestha A; Kolli B; Gilman-Sachs A; Beaman KD
    Oncogene; 2014 Dec; 33(49):5649-54. PubMed ID: 24362525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.
    Kim YJ; Choi JS; Seo J; Song JY; Lee SE; Kwon MJ; Kwon MJ; Kundu J; Jung K; Oh E; Shin YK; Choi YL
    Int J Cancer; 2014 May; 134(10):2424-36. PubMed ID: 24615768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells.
    Hinton A; Sennoune SR; Bond S; Fang M; Reuveni M; Sahagian GG; Jay D; Martinez-Zaguilan R; Forgac M
    J Biol Chem; 2009 Jun; 284(24):16400-16408. PubMed ID: 19366680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer.
    Valcourt DM; Dang MN; Scully MA; Day ES
    ACS Nano; 2020 Mar; 14(3):3378-3388. PubMed ID: 32083466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma.
    Di Cristofori A; Ferrero S; Bertolini I; Gaudioso G; Russo MV; Berno V; Vanini M; Locatelli M; Zavanone M; Rampini P; Vaccari T; Caroli M; Vaira V
    Oncotarget; 2015 Jul; 6(19):17514-31. PubMed ID: 26020805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of silkworm vacuolar-type ATPase activity by its inhibitor Bafilomycin A1 induces caspase-dependent apoptosis in an embryonic cell line of silkworm.
    Tan XY; Wang X; Liu QS; Xie XQ; Li Y; Li BQ; Li ZQ; Xia QY; Zhao P
    Arch Insect Biochem Physiol; 2018 Nov; 99(3):e21507. PubMed ID: 30246413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and role of a2 vacuolar-ATPase (a2V) in trafficking of human neutrophil granules and exocytosis.
    Gilman-Sachs A; Tikoo A; Akman-Anderson L; Jaiswal M; Ntrivalas E; Beaman K
    J Leukoc Biol; 2015 Jun; 97(6):1121-31. PubMed ID: 25877929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells.
    Capecci J; Forgac M
    J Biol Chem; 2013 Nov; 288(45):32731-32741. PubMed ID: 24072707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The putative endogenous AHR ligand ITE reduces JAG1 and associated NOTCH1 signaling in triple negative breast cancer cells.
    Piwarski SA; Thompson C; Chaudhry AR; Denvir J; Primerano DA; Fan J; Salisbury TB
    Biochem Pharmacol; 2020 Apr; 174():113845. PubMed ID: 32032581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.